StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Prakash Gaba

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))3 Jul 2026via CNBC Awaaz.

Entry₹1,133Inferred
Target₹1,150
Total upside +1.50% (call closed)
Stop loss₹1,125-0.71% risk
Exit₹1,1506 Jul 2026, 12:35 pm
Target hit+1.50%0.00%upside left
Follow Prakash Gaba for new calls(30% target hit, 299 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:34 pm IST
5 supporting1 neutral0 opposing
Supports the BUY call (5)

1 advisor has an active intraday BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·6 Jul · today

Zydus Lifesciences Limited has signed an MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test (MCD) in India.

NSE · Press Release·3 Jul · 3d ago

(opens in new tab)

Zydus Lifesciences Ltd. has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to expand access to the Shield™ Multi-Cancer Detection test (MCD) in India. This test screens for 10 common

BSE · Company Update·3 Jul · 3d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·3 Jul · 3d ago

Zydus Lifesciences Ltd provided an update on the acquisition of an API business.

BSE · Company Update·29 Jun · 6d ago

(opens in new tab)
Neutral / worth noting (1)

Zydus Lifesciences Limited has extinguished 87,30,158 equity shares as part of its buyback program. This action reduces the total number of outstanding shares.

BSE · Company Update·19 Jun · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Prakash Gaba

Every call and its outcome